The Chile Neurology Devices Market is witnessing steady growth due to the rising prevalence of neurological disorders such as stroke, epilepsy, Parkinson’s disease, and brain aneurysms. An aging population and increasing awareness about early neurological diagnosis are driving demand for advanced neurosurgical and neurostimulation devices. Improvements in healthcare infrastructure and access to specialized neurology services are also supporting market expansion. Additionally, technological advancements in minimally invasive neurosurgery and real-time brain monitoring systems are enhancing patient outcomes across Chile.

What Is the Chile Neurology Devices Market Size and Forecast?

The Chile Neurology Devices Market size was approximately USD 43.80 Million in 2025. The market is projected to grow at a CAGR of 2.80% between 2026 and 2035, reaching around USD 57.73 Million by 2035. This moderate growth is driven by increasing demand for neurothrombectomy devices and neurostimulation systems, particularly in urban hospitals equipped with advanced surgical facilities.

Chile Neurology Devices Market Share by Type

The Chile Neurology Devices Market share is segmented by type into cerebrospinal fluid management devices, interventional neurology devices, neurosurgery devices, and neurostimulation devices. Interventional neurology devices, including neurothrombectomy devices, carotid artery stents, and embolic coils, hold a significant share due to the increasing incidence of stroke. Neurostimulation devices such as spinal cord stimulation and deep brain stimulation systems are gaining traction for managing chronic pain and movement disorders.

Neurosurgery devices, including neuroendoscopes, stereotactic systems, and aneurysm clips, are also contributing to market growth as hospitals adopt advanced surgical technologies.

Request sample report Explore

Chile Neurology Devices Market Trends and End-Use Insights

Key Chile Neurology Devices Market trends include the growing adoption of minimally invasive procedures, integration of imaging-guided technologies, and expansion of neuro-rehabilitation services. Hospitals represent the largest end-use segment due to their comprehensive neurology departments and surgical capabilities. Ambulatory surgery centres are gradually expanding their presence, particularly for less complex neurological interventions.

Major companies operating in the market include B. Braun Melsungen SE, Stryker Corporation, Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., and Integra Lifesciences Corporation. These players focus on product innovation and partnerships to strengthen their footprint in Chile.